Chao Wu

7.6k total citations
189 papers, 3.1k citations indexed

About

Chao Wu is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Chao Wu has authored 189 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Epidemiology, 76 papers in Hepatology and 43 papers in Infectious Diseases. Recurrent topics in Chao Wu's work include Liver Disease Diagnosis and Treatment (71 papers), Hepatitis B Virus Studies (60 papers) and Hepatitis C virus research (50 papers). Chao Wu is often cited by papers focused on Liver Disease Diagnosis and Treatment (71 papers), Hepatitis B Virus Studies (60 papers) and Hepatitis C virus research (50 papers). Chao Wu collaborates with scholars based in China, United States and Taiwan. Chao Wu's co-authors include Rui Huang, Yuxin Chen, Xiaomin Yan, Feng Tian, J.A. McDonald, Juan Xia, R. L. Juliano, Jeffrey S. Bauer, Yali Xiong and Xuejin Gao and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Chao Wu

176 papers receiving 3.1k citations

Peers

Chao Wu

EPIDE

HEPAT

SURGE

Zuojiong Gong China

Li Chen China

Saurabh Kedia India

Daniela Francisci Italy

Tony Bruns Germany

Stelios F. Assimakopoulos Greece

Yueyong Zhu China

Meifang Han China

Salvador Resino Spain

Ding Shi China

Zuojiong Gong China

Chao Wu

1.0k ×1.0

1.1k ×1.1

EPIDE

523 ×0.8

HEPAT

1.1k ×2.2

300 ×0.9

SURGE

Citations per year, relative to Chao Wu Chao Wu (= 1×) peers Zuojiong Gong

Countries citing papers authored by Chao Wu

Since Specialization

Citations

This map shows the geographic impact of Chao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Wu more than expected).

Fields of papers citing papers by Chao Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Wu. The network helps show where Chao Wu may publish in the future.

Co-authorship network of co-authors of Chao Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chao Wu. A scholar is included among the top collaborators of Chao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao Wu. Chao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yeo, Yee Hui, Xiang Gao, Fajuan Rui, et al.. (2025). Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): A Population‐Based Cohort Study. Alimentary Pharmacology & Therapeutics. 62(2). 168–179. 5 indexed citations

Wang, Jian, Jie Zhan, Zhiyi Zhang, et al.. (2025). Prevalence and clinical significance of HBeAg-positive chronic hepatitis B patients with and without anti-HBe antibody. Virulence. 16(1). 2534079–2534079.

Li, Yuanyuan, Jian Wang, Xiaomin Yan, et al.. (2024). HBeAg-positive CHB patients with indeterminate phase associated with a high risk of significant fibrosis. Virology Journal. 21(1). 287–287. 1 indexed citations

Wang, Jian, et al.. (2024). WHO 2024 Hepatitis B Guidelines and Treatment-Eligible Rate Among Treatment-Naive Patients. JAMA Network Open. 7(9). e2435777–e2435777.

Chen, Yuxin, Tiantian Zhao, Lin Chen, et al.. (2024). SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients. mBio. 15(4). e0240723–e0240723. 5 indexed citations

Chen, Yuxin, Ming Li, Jian Wang, et al.. (2024). Virological and Immunological Characteristics of HBeAg ‐Positive Chronic Hepatitis B Patients With Low HBsAg Levels. Alimentary Pharmacology & Therapeutics. 61(5). 814–823.

Zhang, Yanping, Yuetong Li, Xin Yu, et al.. (2023). SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma. BMC Cancer. 23(1). 1159–1159. 5 indexed citations

Wang, Jian, Zhiyi Zhang, Yuanwang Qiu, et al.. (2023). Development and Validation of a Nomogram to Predict Significant Liver Inflammation in Patients with Chronic Hepatitis B. Infection and Drug Resistance. Volume 16. 5065–5075. 1 indexed citations

Wang, Jian, Rui Huang, Jiacheng Liu, et al.. (2023). A novel non‐invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD. Journal of Viral Hepatitis. 30(4). 287–296. 5 indexed citations

10.

Yin, Shengxia, Jian Wang, Lin Chen, et al.. (2023). Circulating Th2-biased T follicular helper cells impede antiviral humoral responses during chronic hepatitis B infection through upregulating CTLA4. Antiviral Research. 216. 105665–105665. 1 indexed citations

11.

Wang, Huali, Jian Wang, Juan Xia, et al.. (2020). Red cell distribution width to platelet ratio predicts liver fibrosis in patients with autoimmune hepatitis. Medicine. 99(34). e21408–e21408. 10 indexed citations

12.

Zhu, Li, Jian Wang, Rui Huang, et al.. (2020). Clinical characteristics of a case series of children with coronavirus disease 2019. Pediatric Pulmonology. 55(6). 1430–1432. 63 indexed citations

13.

Li, Yang, Shengxia Yin, Yuxin Chen, et al.. (2020). Hepatitis B virus‐induced hyperactivation of B cells in chronic hepatitis B patients via TLR4. Journal of Cellular and Molecular Medicine. 24(11). 6096–6106. 13 indexed citations

14.

Wang, Jian, Rui Huang, Xiaomin Yan, et al.. (2020). Red blood cell distribution width: A promising index for evaluating the severity and long-term prognosis of hepatitis B virus–related diseases. Digestive and Liver Disease. 52(4). 440–446. 12 indexed citations

15.

Xu, Tianmin, Rui Huang, Li Zhu, et al.. (2020). Epidemiological and clinical features of asymptomatic patients with SARS‐CoV‐2 infection. Journal of Medical Virology. 92(10). 1884–1889. 41 indexed citations

16.

Wu, Chao, et al.. (2019). Incidence, risk factors, and prognosis in patients with primary hepatocellular carcinoma and lung metastasis: a population-based study. SHILAP Revista de lepidopterología. 1 indexed citations

17.

Wang, Jian, Zhaoping Zhang, Xiaomin Yan, et al.. (2019). Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis. Digestive and Liver Disease. 51(8). 1172–1178. 49 indexed citations

18.

Zhao, Xiang‐An, Guangmei Chen, Yong Liu, et al.. (2018). Curcumin reduces Ly6Chi monocyte infiltration to protect against liver fibrosis by inhibiting Kupffer cells activation to reduce chemokines secretion. Biomedicine & Pharmacotherapy. 106. 868–878. 38 indexed citations

19.

Wang, Jia, Juan Xia, Xiaomin Yan, et al.. (2018). A novel index using routine clinical parameters for predicting significant liver inflammation in chronic hepatitis B. Journal of Viral Hepatitis. 25(10). 1151–1160. 14 indexed citations

20.

Yang, Rui, Yaming Yang, Chao Wu, et al.. (2016). [Evaluation on Malaria Hotspots in Yingjiang County of the China-Myanmar Border Area in 2015].. PubMed. 34(5). 430–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact